| 发明名称 |
Composition for treating dementia and Alzheimer's disease |
| 摘要 |
Controlled release dosage forms useful in the treatment and/or prophylaxis of dementia, including Alzheimer's disease, in mammals, and for enhancing amyloid precursor protein processing along a non-amyloidogenic pathway in patients suffering from, or at risk of developing, Alzeimer's disease.
|
| 申请公布号 |
US6451343(B1) |
申请公布日期 |
2002.09.17 |
| 申请号 |
US20000623213 |
申请日期 |
2000.08.30 |
| 申请人 |
SMITHKLINE BEECHAM CORPORATION;SMITHKLINE BEECHAM P.L.C. |
发明人 |
GLINECKE ROBERT;MULDOON WILLIAM;MILOSOVICH SUSAN MARIE;SAUER JOSEPH;ROUSSEAU LAURENCE |
| 分类号 |
A61K9/20;A61K9/22;A61K9/28;A61K9/30;A61K9/40;A61K9/48;A61K31/439;A61P25/28;A61P43/00;(IPC1-7):A61K9/40 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
